Medication info
Atracen Semis Tablet

Atracen Semis Tablet

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›162.5mg / 1 tabletTramadol Hydrochloride›18.75mg / 1 tablet
Manufacturer / importer
Korea Union Pharmaceutical Co., Ltd.
Appearance
Light yellow oblong film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202003201 · Approved 2020.04.29 · Insurance code 665508230

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Elderly Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when tramadol was administered orally to patients aged 75 years or older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this medicine after dialysis to maintain its analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older: Adjust the dose according to the patient's pain severity and response to treatment. An initial dose of 4 tablets is recommended; thereafter, allow an interval of at least 6 hours between doses and do not exceed 16 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Ingredients

Manufacturer
Korea Union Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute and chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Elderly Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when tramadol was administered orally to patients aged 75 years or older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this medicine after dialysis to maintain its analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older: Adjust the dose according to the patient's pain severity and response to treatment. An initial dose of 4 tablets is recommended; thereafter, allow an interval of at least 6 hours between doses and do not exceed 16 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Precautions

This medication may burden the liver, so individuals who consume large amounts of alcohol daily should consult with a doctor or pharmacist before taking this drug. There is a risk of liver damage. This drug can rarely cause serious skin reactions; if a rash or hypersensitivity occurs, discontinue use immediately and seek medical attention. The tramadol component of this medication may induce seizures; therefore, patients with a history of seizures or those at high risk of seizures should be cautious. The risk of seizures increases especially when taken with certain antidepressants or opioids. Serious allergic reactions can occur occasionally; seek emergency treatment if symptoms like difficulty breathing or hives appear. In patients with acute bronchial asthma, this medication may severely suppress breathing, so it must be administered in a medically equipped environment. Taking this drug with alcohol or central nervous system depressants may lead to severe drowsiness, respiratory depression, or coma, so co-administration should be avoided. In patients with brain injuries or elevated intracranial pressure, this drug may worsen their condition, requiring caution. This medication may cause both psychological and physical dependence, so long-term use should strictly follow a doctor's instructions. As the acetaminophen component can harm the liver, patients with liver diseases or compromised liver function must consult with a doctor before use. Patients who metabolize tramadol rapidly due to genetic factors may be at a higher risk of respiratory depression, requiring dose adjustment and careful monitoring. Children under 12 years old and adolescents under 18 years who have undergone tonsillectomy or adenoidectomy should not use this drug, and adolescents aged 12 to 18 should also avoid it if there are risk factors. This medication may cause sleep apnea or hypoxia, and if such symptoms appear or worsen, it is necessary to reduce or discontinue the dosage. Elderly patients or those at risk for hyponatremia should be closely observed for potential development of hyponatremia. This drug may interact with certain medications, so patients must inform their doctor or pharmacist about any other medications they are taking. Women who are pregnant or may become pregnant, as well as nursing mothers, should consult with healthcare professionals before taking this drug, as it could have serious effects on the baby during breastfeeding. Drowsiness or dizziness may occur during use, so caution is advised when driving or operating machinery. In case of overdose, serious respiratory depression, seizures, liver damage, etc., may occur, so the recommended dosage must be strictly adhered to, and in case of overdose, immediate emergency treatment is required. This medication should be stored in a safe place out of the reach of children, and care should be taken to prevent misuse or abuse.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, fatal respiratory depression, hyponatremia, decreased appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, indigestion, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, hyperexcitability, emotional instability, euphoria, decreased libido, sleep disturbances, confusion, disorientation, agitation, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, hypersomnia, sensory loss, tremors, sensory abnormalities, attention deficit, syncope, memory impairment, psychomotor hyperactivity, sedation, amnesia, perceptual disturbances, convulsions, blurred vision, visual impairment, miosis, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, increased liver enzymes, generalized pruritus, cold sweats, urinary disturbances, erectile dysfunction, asthenia, chest pain, emotional abnormalities, chills, chest discomfort, fatigue, thirst, irritability, heat sensation, weight loss, increased serum creatinine, anaphylactic reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, effects on emotional instability, delirium, suicidal ideation, muscle rigidity, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbances, prolonged prothrombin time, thrombocytopenia, agranulocytosis, blood disorders, hypoprothrombinemia, high anion gap metabolic acidosis, fixed rash, asthenia, fever, edema, rigidity, syncope, congestive heart failure, vertigo, confusion, exacerbation of migraine, involuntary muscle contractions, obstructive respiratory distress, cough, bronchitis, urinary retention, increased urination, abnormal kidney function tests, oliguria, increased sweating, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, increased white blood cells, leukocytosis, palpitations, arrhythmia, exacerbation of hypertension, aortic stenosis, gastrointestinal bleeding, elevated cholesterol, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, epistaxis, abnormal vision, progression of biliary cancer, foreign body sensation in the eye, progression of liver cancer, liver dysfunction, nausea, dizziness, paralytic ileus, cholecystitis, abnormal kidney function tests, increased salivation, gastrointestinal bleeding, nausea, dizziness, dyspnea, confusion, migraine, speech disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, vomiting, indigestion, confusion, multiple organ failure, anaphylaxis, intentional overdose, belching, chest discomfort, anxiety, sweating, rigidity, pain, diarrhea, upper respiratory syndrome, lip tremor, agitation, hyperexcitability, hyperactivity, panic attacks, severe anxiety, hallucinations, perceptual disturbances, tinnitus, abnormal central nervous system responses, urticaria, bronchospasm, toxic skin necrosis, opioid-induced hyperalgesia, withdrawal symptoms, acute or chronic adrenal insufficiency, severe abdominal pain, hypotension, extreme fatigue, decreased appetite, weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to prevent air or moisture exposure. It is also recommended to keep it away from direct sunlight and at room temperature below 25 degrees Celsius.

Appearance and packaging

Appearance

Light yellow oblong film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.